# Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy

> **NCT06974097** · — · NOT_YET_RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 72 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **OTHER:** blood sampling

## Key facts

- **NCT ID:** NCT06974097
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2028-07-28
- **Final completion:** 2028-12-30
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06974097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06974097, "Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06974097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*